How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

OPS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.76%

Insider Buying (Last 12 Months): C$0.00

Insider Selling (Last 12 Months): C$0.00

Opsens Insider Trading History Chart

Opsens Share Price & Price History

C^$2.89

+0.30 (1.20%)

As of 12/8/2023 01:00 AM ET

Days: 30 | 90 | 365

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

Opsens Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/25/2022	Louis Laflamme	Director	Buy	1,000	C$2.00	C$2,000.00	516,000
5/26/2022	Robin Villeneuve	Senior Officer	Sell	50,000	C$2.11	C$105,500.00	35,000
5/19/2022	Robin Villeneuve	Senior Officer	Sell	50,000	C$1.79	C$89,630.00	35,000
4/20/2022	Robin Villeneuve	Senior Officer	Sell	40,000	C$2.36	C$94,308.00	35,000
1/27/2022	Robin Villeneuve	Senior Officer	Sell	50,000	C$2.06	C$103,000.00	30,000

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Opsens (TSE:OPS)

21.40% of Opsens stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company offers fiber optic temperature, pressure, strain, and displacement sensor products; and fiber optic extensometer and signal conditioner/OEM boards. It serves energy, aerospace and defense, industrial and laboratory, smart structure health monitoring, geotechnical, and power electronics and semiconductors markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada.

Today's Range

Now: C$2.89

C$2.89

C$2.90

50 Day Range

MA: C$2.73

C$1.73

C$2.89

52 Week Range

Now: C$2.89

C$1.36

C$2.90

Volume

67,003 shs

Average Volume

113,119 shs

Market Capitalization

C$334.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.34

Who are the company insiders with the largest holdings of Opsens?: Opsens' top insider shareholders include:
Louis Laflamme (Director)
Robin Villeneuve (Senior Officer)
Learn More about top insider investors at Opsens.